Guided treatment vs usual care for stubborn depression
Treatments studied
Part of Mental health clinical trials.
This trial tests if using an algorithm to guide treatment works better than standard care for people whose depression hasn't gotten better with previous treatments. It aims to find a more effective approach for those with treatment-resistant depression.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with unipolar depression (not bipolar).
- Your depression has not been in stable remission for at least 12 months.
- You score at least 21 on a depression severity questionnaire (MDI).
- You are between 18 and 64 years old.
- You are currently taking medication for depression.
- You have not changed your depression treatment in the last 4 weeks.
- You are an outpatient (not hospitalized).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of brain stimulation treatment for people with major depression that hasn't improved with standard treatments. The treatment uses magnetic pulses to target specific brain areas over about 2 weeks.
This study combines a new experimental medication (NRX-101) with robotic brain stimulation (TMS) to see if it improves depression symptoms. It is for people who have not had success with at least two other depression treatments.
This study uses a blood test (biomarker) to help pick the antidepressant that might work best for you. It compares two treatments—standard antidepressants and ketamine—in people with major depression who haven't gotten enough relief from one prior treatment.
This study tests a new way of delivering brain stimulation called rTMS to treat depression that hasn't improved with standard treatments. The goal is to see if targeting specific brain areas helps reduce depression symptoms more effectively.
This study helps people with moderate depression decide between medication and therapy. Your doctor will work with you to pick the best option.
This study looks at how people with treatment-resistant depression engage in their care. It does not test a new treatment but aims to understand patterns, which may help improve future care.
Hear when a new Treatment Resistant Depression (TRD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.